科拓生物：2025年前三季度净利润约7623万元

Group 1 - The core viewpoint of the article highlights the financial performance of Keta Bio, reporting a revenue of approximately 267 million yuan for the first three quarters of 2025, representing a year-on-year increase of 22.25% [1] - The net profit attributable to shareholders of the listed company is approximately 76.23 million yuan, reflecting a year-on-year increase of 7.08% [1] - The basic earnings per share is reported at 0.29 yuan, which is a year-on-year increase of 7.41% [1]